Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India.

Autor: Munusamy Ponnan S; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Hayes P; IAVI Human Immunology Laboratory, Imperial College, London, England, United Kingdom., Fernandez N; IAVI Human Immunology Laboratory, Imperial College, London, England, United Kingdom., Thiruvengadam K; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Pattabiram S; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Nesakumar M; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Srinivasan A; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Kathirvel S; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Shankar J; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Goyal R; International AIDS Vaccine Initiative, New Delhi, India., Singla N; International AIDS Vaccine Initiative, New Delhi, India., Mukherjee J; International AIDS Vaccine Initiative, New Delhi, India., Chatrath S; International AIDS Vaccine Initiative, New Delhi, India., Gilmour J; IAVI Human Immunology Laboratory, Imperial College, London, England, United Kingdom., Subramanyam S; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Prasad Tripathy S; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Swaminathan S; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Hanna LE; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India.

Publikováno v: PloS one [PLoS One] 2020 Feb 25; Vol. 15 (2), pp. e0229461. Date of Electronic Publication: 2020 Feb 25 (Print Publication: 2020).

Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.

Autor: Munusamy Ponnan S; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Swaminathan S; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Tiruvengadam K; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., K K V; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Cheedarla N; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Nesakumar M; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Kathirvel S; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Goyal R; International AIDS Vaccine Initiative, New Delhi, India., Singla N; International AIDS Vaccine Initiative, New Delhi, India., Mukherjee J; International AIDS Vaccine Initiative, New Delhi, India., Bergin P; IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom., T Kopycinski J; IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom., Gilmour J; IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom., Prasad Tripathy S; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India., Luke HE; National Institute for Research in Tuberculosis (Indian Council of Medical Research), Chennai, India.

Publikováno v: PloS one [PLoS One] 2018 Aug 29; Vol. 13 (8), pp. e0203037. Date of Electronic Publication: 2018 Aug 29 (Print Publication: 2018).